Day: May 28, 2020
Highlights:Mineralised intersection of 32.0 g/t Au over 2.0 m included within 16.5 g/t Au over 4.5 m, also included within 7.1 g/t Au over 12.1 m, located 500 m below the new Zones 5B4-5M4-5NE in the East Sector of the Chimo Mine Property; The results of this press release, factored with those of the May 21st2020, April 7th2020 and February 18th2020 press releases, increase the potential for expansion of the resource estimate to date for the new Zones 5B4-5M4-5NE (FIGURE); The Chimo Mine Property hosts three gold-bearing corridors (North, Central and South) that to date host the following mineral resources: — 4,017,600 tonnes at an average grade of 4.53 g/t Au for a total of 585,190 ounces gold in the Indicated Category;— 4,877,900 tonnes at an average grade of 3.82 g/t Au for a total of 597,800 ounces gold in the Inferred...
Cartier recoupe 16,5 g/t Au sur 4,5 m à Mine Chimo 500 m sous les nouvelles Zones 5B4-5M4-5NE
Written by Customer Service on . Posted in Public Companies.
Faits saillants :Intersection minéralisée de 32,0 g/t Au sur 2,0 m incluse dans 16,5 g/t Au sur 4,5 m, elle-même incluse dans 7,1 g/t Au sur 12,1 m, à une distance de 500 m sous les nouvelles Zones 5B4-5M4-5NE du Secteur Est ;Les résultats de ce communiqué, associés à ceux du 21 mai 2020, 7 avril 2020 et du 18 février 2020, accroissent considérablement le potentiel d’expansion des ressources estimées à ce jour pour les nouvelles Zones 5B4-5M4-5NE (FIGURE) ;La propriété Mine Chimo contient trois Couloirs Aurifères (Nord, Central et Sud) et possède à ce jour les ressources minérales suivantes :— 4 017 600 tonnes à une teneur moyenne de 4,53 g/t Au pour un total de 585 190 onces d’or dans la catégorie de ressources indiquées ;— 4 877 900 tonnes à une teneur moyenne de 3,82 g/t Au pour un total de 597 800 onces d’or dans la catégorie...
WPD Pharmaceuticals Licensor Granted Another Key Patent for the Development of WPD101 Drug Candidate
Written by Customer Service on . Posted in Public Companies.
VANCOUVER, British Columbia, May 28, 2020 (GLOBE NEWSWIRE) — WPD Pharmaceuticals Inc. (CSE: WBIO)(FSE: 8SV1) (the “Company” or “WPD”), a clinical stage pharmaceutical company, is pleased to announce that on May 21, 2020 Wake Forest University received a patent from the United States Patent and Trademark Office (“USPTO”) for a patent titled “EphA3 and Multi-Valent Targeting of Tumors” (under application number 15/958,608). The patent is exclusively licensed to WPD, and the patent relates to the WPD101 drug candidate, used in the therapy of glioblastoma multiform (“GBM”). Mariusz Olejniczak, CEO of WPD commented, “We are very excited to receive another patent included in the license agreement with Wake Forest University. This patent covers EPHA3 and multi-valent targeting of tumors and provides an additional layer of protection for...
Osino Resources Drills Additional Wide Gold Intercepts and Further Increases Strike of Mineralization at Twin Hills Central Discovery, Namibia
Written by Customer Service on . Posted in Public Companies.
Assays have been received for the first 4 holes of the 2020 drill program at Twin Hills CentralHighlights from the latest results include: ∙ 150m @ 0.98g/t (OKD031: 23 – 173m), incl. 61m @ 1.51g/t ∙ 77m @ 0.72g/t (OKD032: 98 – 175m), incl. 15m @ 1.33g/t and 12m @ 1.36g/t ∙ 10m @ 1.23g/t (OKD030: 25 – 35m)Gold mineralized strike extended to 1300m, open to the east, west and down dipA total of 2,000m of the 20,000m drill program planned for 2020 has been completed so far with two diamond rigs active at Twin Hills Central, and a third rig active at Twin Hills WestThe objective of the program is expansion drilling and resource definition at Twin Hills Central as well as additional satellite discovery along strike, aiming to complete a NI 43-101 compliant maiden resource report for Twin Hills Central in the first half of 2021VANCOUVER,...
Translate Bio to Present at Jefferies Virtual Healthcare Conference
Written by Customer Service on . Posted in Public Companies.
LEXINGTON, Mass., May 28, 2020 (GLOBE NEWSWIRE) — Translate Bio (Nasdaq: TBIO), a clinical-stage messenger RNA (mRNA) therapeutics company developing a new class of potentially transformative medicines to treat diseases caused by protein or gene dysfunction, today announced that Ronald Renaud, chief executive officer, will participate in a fireside chat at the Jefferies Virtual Healthcare Conference on Wednesday, June 3, 2020, at 1:00 p.m. ET.A live webcast of the session will be accessible through the “Events and Presentations” page of the Company’s website at investors.translate.bio. A replay of the webcast will be archived on the Translate Bio’s website for 30 days following the presentation.About Translate BioTranslate Bio is a clinical-stage mRNA therapeutics company developing a new class of potentially transformative...
Abercrombie & Fitch Co. Reports First Quarter Results
Written by Customer Service on . Posted in Public Companies.
Company continues to reopen stores globally on a rolling basis with roughly half of the fleet currently openQ1 results reflect strong cash flow management and month-over-month acceleration in digital sales growth, partially offsetting sales decline from temporary store closuresNet loss per diluted share of $3.90 reflects adverse tax impacts of $1.45 related to valuation allowances on deferred tax assets and other tax charges and $0.62 related to asset impairment chargesNEW ALBANY, Ohio, May 28, 2020 (GLOBE NEWSWIRE) — Abercrombie & Fitch Co. (NYSE: ANF) today announced results for the first quarter ended May 2, 2020. These compare to results for the first quarter ended May 4, 2019. Descriptions of the use of non-GAAP financial measures and reconciliations of GAAP and non-GAAP financial measures accompany this release.Details...
MacroGenics Provides Update on FDA Review of Margetuximab for HER2-Positive Metastatic Breast Cancer
Written by Customer Service on . Posted in Public Companies.
– Advisory committee meeting not required; PDUFA goal date unchangedRockville, MD, May 28, 2020 (GLOBE NEWSWIRE) —MacroGenics, Inc. (NASDAQ: MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for the treatment of cancer, today announced that during the recent mid-cycle communication with the U.S. Food and Drug Administration (FDA), the FDA notified the Company that it is no longer planning to hold an Oncologic Drugs Advisory Committee (ODAC) meeting to discuss the Biologics License Application (BLA) for margetuximab. The FDA also stated it continues to anticipate meeting the Prescription Drug User Fee Act (PDUFA) goal date for the application review, which is December 18, 2020.“Since submitting the BLA for margetuximab, we have worked...
DraftKings Sportsbook Expands Partnership with Sportradar to Launch Mobile Live Streaming
Written by Customer Service on . Posted in Public Companies.
BOSTON, May 28, 2020 (GLOBE NEWSWIRE) — Today, DraftKings Sportsbook has announced it will offer live-streamed sports games within its award-winning mobile app. In collaboration with Sportradar, the global provider of sports data and content, DraftKings Sportsbook will provide customers with a seamless entertainment experience in one convenient location.Pursuant to state regulations, DraftKings Sportsbook customers who are logged in to their active accounts and have a wallet balance above $0.00 will have the ability to live stream games directly within the mobile app. At launch, DraftKings Sportsbook geolocated customers will be able to live stream a number of sports, including the Korea Baseball Organization and Bundesliga Soccer (Division 1) across all jurisdictions except Iowa. With over 100 different leagues in total on the...
Deveron Reports Q1 Revenue Growth of 181%
Written by Customer Service on . Posted in Public Companies.
TORONTO, May 28, 2020 (GLOBE NEWSWIRE) — Deveron UAS Corp. (CSE: DVR) (“Deveron” or the “Company”), a leading agriculture digital services and insights provider in North America, is pleased to announce revenue growth of 181% year over year to $283,420 in Q1 2020. For the fourth quarter in a row, Deveron achieved sales growth of over 100%.First Quarter 2020 Financial and Operational HighlightsThe Company’s financial performance improved over the previous year’s quarter, driven by the continued customer uptake of Deveron’s soil sampling service. For the three-month financial results ended March 31, 2020 (and comparable period ended March 31, 2019):Revenue grew 181% year over year to $283,420 in Q1 2020, from $100,564 in Q1 2019. Gross profit grew 160% year over year to $180,212 in Q1 2020, from $69,833 in Q1 2019.“Our first quarter...
Biogen and MIT Launch New Virtual Learning Lab for High School Students Historically Underrepresented in Science
Written by Customer Service on . Posted in Public Companies.
The online learning program combines lab simulations and mentoring experiences focused on biotechnology and neurological diseases, such as Parkinson’s disease, Alzheimer’s disease and multiple sclerosisFour hundred students from Massachusetts and North Carolina are enrolling in this no-fee program that also provides students with computers and other technology resourcesThe initiative builds upon Biogen’s Community Lab, which has enrolled more than 55,000 students to date, and the Lemelson-MIT Program in inspiring the next generation of creative and inventive problem-solversCAMBRIDGE, Mass., May 28, 2020 (GLOBE NEWSWIRE) — Biogen Inc. (Nasdaq: BIIB) is bringing its well-recognized Community Lab science learning program together with the Lemelson-MIT Program (LMIT) at the Massachusetts Institute of Technology to launch the new online...